Abstract
This chapter presents a comprehensive review of various neuropathology topics starting with an overview of the normal CNS histology and reactions to injury to a detailed discussion of various CNS tumors and their classification, sellar/suprasellar region pathologies, trauma, vascular disorders, neurodegenerative diseases, inflammatory and infectious disorders, pediatric and developmental abnormalities, and toxic and metabolic conditions. The authors attempted to strike a balance between completeness, depth of material covered, and relevance to various levels of readers. There is an emphasis on recent molecular advances and how they influence the classification of CNS tumors and neurodegenerative conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Suggested Reading
Histology/General Reactions
Ellison D, Love S, et al. Neuropathology: a reference text of CNS pathology. 3rd ed. Edinburgh: Mosby/Elsevier; 2013.
Diffuse Gliomas
Appin CL, Brat DJ. Molecular genetics of gliomas. Cancer J. 2014;20:66–72.
Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372:2481–98.
Huse JT, Aldape KD. The evolving role of molecular markers in the diagnosis and management of diffuse glioma. Clin Cancer Res. 2014;20:5601–11.
Khuong-Quang DA, Buczkowicz P, Rakopoulos P, et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 2012;124:439–47.
Komori T. Pathology and genetics of diffuse gliomas in adults. Neurol Med Chir. 2015;55:28–37.
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, editors. WHO classification of tumours of the central nervous system, WHO Classification of Tumours. 4th ed. Lyon: IARC Press; 2007.
Morales H, Gaskill-Shipley M. Imaging of common adult and pediatric primary brain tumors. Semin Roentgenol. 2010;45:92–106.
Perry A, Brat DJ. Practical surgical neuropathology. Philadelphia: Churchill Livingstone Elsevier; 2010.
Reis GF, Pekmezci M, Hansen H, et al. CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization grades II-III) astroctyomas. J Neuropathol Exp Neurol. 2015;74:442–52.
Rodriguez FJ, Giannini C. Oligodendroglial tumors: diagnostic and molecular pathology. Semin Diagn Pathol. 2010;27:136–45.
Sahm F, Reuss D, Koelsche C, et al. Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. Acta Neuropathol. 2014;128:551–9.
Other Gliomas
Brat DJ, Scheithauer BW, Staugaitis SM, Cortez SC, Brecher K, Burger PC. Third ventricular chordoid glioma: a distinct clinicopathologic entity. J Neuropathol Exp Neurol. 1998;57:283–90.
Buccoliero AM, Franchi A, Castiglione F, et al. Subependymal giant cell astrocytoma (SEGA): is it an astrocytoma? Morphological, immunohistochemical and ultrastructural study. Neuropathology. 2009;29:25–30.
Chen YH, Gutmann DH. The molecular and cell biology of pediatric low-grade gliomas. Oncogene. 2014;33:2019–26.
Dias-Santagata D, Lam Q, Vernovsky K, et al. BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications. PLoS One. 2011;6:e17948.
Gajjar A, Pfister SM, Taylor MD, Gilbertson RJ. Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin Cancer Res. 2014;20:5630–40.
Pajtler KW, Witt H, Sill M, et al. Molecular classification of ependymal tumors across all cns compartments, histopathological grades, and age groups. Cancer Cell. 2015;27:728–43.
Rodriguez FJ, Lim KS, Bowers D, et al. Pathological and molecular advances in pediatric astrocytoma. Annu Rev Pathol. 2013;24:361–79.
Sonneland PR, Scheithauer BW, Onofrio BM. Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer. 1985;56:883–93.
Vege KDS, Giannini C, Scheithauer BW. The immunophenotype of ependymomas. Appl Immunohistochem Mol Morphol. 2000;8:25–31.
Yao Y, Mack SC, Taylor MD. Molecular genetics of ependymoma. Chin J Cancer. 2011;30:669–81.
Neuronal and Mixed Glioneuronal Tumors
Edgar MA, Rosenblum MK. Mixed glioneuronal tumors: recently described entities. Arch Pathol Lab Med. 2007;131:228–33.
Patel DM, Schmidt RF, Liu JK. Update on the diagnosis, pathogenesis, and treatment strategies for central neurocytoma. J Clin Neurosci. 2013;20:1193–9.
Tamburrini G, Colosimo C, Giangaspero F, Riccardi R, Di Rocco C. Desmoplastic infantile ganglioglioma. Childs Nerv Syst. 2003;19:292–7.
Thom M, Blumcke I, Aronica E. Long-term epilepsy-associated tumors. Brain Pathol. 2012;22:350–79.
Thom M, Toma A, An S, et al. One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature. J Neuropathol Exp Neurol. 2011;70:859–78.
VandenBerg SR. Desmoplastic infantile ganglioglioma and desmoplastic cerebral astrocytoma of infancy. Brain Pathol. 1993;3:275–81.
Zhang J, Babu R, McLendon RE, et al. A comprehensive analysis of 41 patients with rosette-forming glioneuronal tumors of the fourth ventricle. J Clin Neurosci. 2013;20:335–41.
Embryonal Tumors
Behdad A, Perry A. Central nervous system primitive neuroectodermal tumors: a clinicopathologic and genetic study of 33 cases. Brain Pathol. 2010;20:441–50.
Ellison DW, Kocak M, Dalton J, et al. Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol. 2011;29:1400–7.
Faragalla H, Weinreb I. Olfactory neuroblastoma: a review and update. Adv Anat Pathol. 2009;16:322–31.
Gessi M, Giangaspero F, Lauriola L, et al. Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor. Am J Surg Pathol. 2009;33:211–7.
Ho DMT, Hsu CY, Wong TT, Ting LT, Chiang H. Atypical teratoid/rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol. 2000;99:482–8.
Korshunov A, Sturm D, Ryzhova M, et al. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol. 2014;128:279–89.
Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg. 1996;85:56–65.
Schwalbe EC, Williamson D, Lindsey JC, et al. DNA methylation profiling of medulloblastoma allows robust sub-classification and improved outcome prediction using formalin-fixed biopsies. Acta Neuropathol. 2013;125:359–71.
Taylor MD, Northcott PA, Korshunov A, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012;123:465–72.
Zhukova N, Ramaswamy V, Remke M, et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol. 2013;31:2927–35.
Meningeal Tumors
Couce ME, Aker FV, Scheithauer BW. Chordoid meningioma. A clinicopathologic study of 42 cases. Am J Surg Pathol. 2000;24:899–905.
Ecker RD, Marsh WR, Pollock BE, et al. Hemangiopericytoma in the central nervous system: treatment, pathological features, and long-term follow up in 38 patients. J Neurosurg. 2003;98:1182–7.
Ludwin SK, Rubinstein LJ, Russell DS. Papillary meningiomas: a malignant variant of meningioma. Cancer. 1975;36:1363–73.
Mena H, Ribas JL, Pezeshkpour GH, et al. Hemangiopericytoma of the central nervous system: a review of 94 cases. Hum Pathol. 1991;22:84–91.
Perry A, Gutmann DH, Reifenberger G. Molecular pathogenesis of meningiomas. J Neurooncol. 2004;70:183–202.
Perry A, Scheithauer BW, Stafford SE, et al. “Rhabdoid” meningioma: an aggressive variant. Am J Surg Pathol. 1998;22:1482–90.
Perry A, Stafford SE, Scheithauer BW, et al. “Malignancy” in meningiomas: a clinicopathologic study of 116 patients. Cancer. 1999;85:2046–56.
Rajaram V, Brat DJ, Perry A. Anaplastic meningioma vs. meningeal hemangiopericytoma: immunohistochemical and genetic markers. Hum Pathol. 2004;135:1413–8.
Riemenschneider MJ, Perry A, Reifenberger G. Histological classification and molecular genetics of meningiomas. Lancet Neurol. 2006;5:1045–54.
Shibuya M. Pathology and molecular genetics of meningioma: recent advances. Neurol Med Chir. 2015;55:14–27.
Tihan T, Viglione M, Rosenblum MC, Olivi A, Burger PC. Solitary fibrous tumors in the central nervous system. A clinicopathologic review of 18 cases and comparison to meningeal hemangiopericytomas. Arch Pathol Lab Med. 2003;127:432–9.
Zorludemir S, Scheithauer BW, Hirose T, et al. Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol. 1995;19:493–505.
Other CNS Tumors
Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg. 2000;92:261–6.
Brastianos PK, Taylor-Weiner A, Manley PE, et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet. 2014;46:161–5.
Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48:55–63.
Crotty TB, Scheithauer BW, Youn Jr WF, et al. Papillary craniopharyngioma: a clinicopathological study of 48 canes. J Neurosurg. 1995;83:206–14.
Hattab EM, Martin SE, Al-Khatib SM, et al. Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases. Mod Pathol. 2010;23:235–43.
Jung SM, Kuo TT. Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma. Mod Pathol. 2005;18:788–94.
Matsutani M, Sano K, Takakura K, et al. Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. J Neurosurg. 1997;86:446–55.
Paulus W. Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neurooncol. 1999;43:203–8.
Schild SE, Scheithauer BW, Haddock MG, et al. Histologically confirmed pineal tumors and other germ cell tumors of the brain. Cancer. 1996;78:2564–71.
Strickland-Marmol LB, Khoor A, Livingston SK, et al. Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain. Arch Pathol Lab Med. 2007;131:1686–90.
Vasiljevic A, Szathmari A, Champier J, et al. Histopathology of pineal germ cell tumors. Neurochirurgie. 2015;61(2–3):130–7.
Wolff JEA, Sajedi M, Brant R, Coppes MJ, Egeler RM. Choroid plexus tumours. Br J Cancer. 2002;87:1086–91.
Sellar/Suprasellar Pathology
Gaffey TA, Scheithauer BW, Lloyd RV, et al. Corticotroph carcinoma of the pituitary: a clinicopathological study. Report of four cases. J Neurosurg. 2002;96:352–60.
Kovacs K, Scheithauer BW, Horvath E, et al. The World Health Organization classification of adenohypophyseal neoplasms. A proposed five-tier scheme. Cancer. 1996;78:502–10.
Lloyd RV, Scheithauer BW, Kovacs K, Roche PC. The immunophenotype of pituitary adenomas. Endocr Pathol. 1996;7:145–50.
Pernicone PJ, Scheithauer BW, Horvath E, Kovacs K. Pituitary and sellar region. In: Sternberg SS, editor. Diagnostic surgical pathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 1997. p. 1053–107.
Perry A, Scheithauer BW. Commentary: classification and grading of pituitary tumors. Observations of two working neuropathologists. Acta Neuropathol. 2006;111:68–70.
Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol. 2007;156:203–16.
Trauma
Crout SE, Flanders AE. Neuropathology of human spinal cord injury. Adv Neurol. 1997;72:317–23.
Geddes JF, Whitwell HE, Graham DI. Traumatic axonal injury: practical issues for diagnosis in medicolegal cases. Neuropathol Appl Neurobiol. 2000;26:105–16.
Graham DI, Adams JH, Nicoll JAR, et al. The nature, distribution and causes of traumatic brain injury. Brain Pathol. 1995;5:397–406.
Hardman JM, Manoukian A. Pathology of head trauma. Neuroimaging Clin North Am. 2002;12:175–87.
Pearl GS. Traumatic neuropathology. Clin Lab Med. 1998;18:39–64.
Vascular Disorders
Black M, Graham DI. Sudden unexplained death in adults caused by intracranial pathology. J Clin Pathol. 2002a;55:44–50.
Kalimo H, Ruchoux MM, Vitanen M, Kalaria RN. CADASIL: a common form of hereditary arteriopathy causing brain infarcts and dementia. Brain Pathol. 2002;12:371–84.
Lammie GA. Hypertensive cerebral small vessel disease and stroke. Brain Pathol. 2002;12:358–70.
Pantoni L, Garcia JH. Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann NY Acad Sci. 1997;826:92–102.
Parisi JE, Moore PM. The role of biopsy in vasculitis of the central nervous system. Semin Neurol. 1994;14:341–8.
Reevesz T, Holton JL, Lashley T, et al. Sporadic and familial cerebral amyloid angiopathies. Brain Pathol. 2002;12:343–57.
Ruchoux MM, Maurage CA. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol. 1997;56:947–64.
Neurodegenerative Diseases
Budka H, Aguzzi A, Brown P, et al. Neuropathological diagnostic criteria for Creutzfeldt–Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathol. 1995;5:459–66.
Chen-Plotkin AS, Lee VM, Trojanowski JQ. TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol. 2010;6:211–20.
Dickson DW. Neuropathology of Alzheimer’s disease and other dementias. Clin Geriatric Med. 2001;17:209–28.
Dickson DW, Weller RO. Neurodegeneration: the molecular pathology of dementia and movement disorders. 2nd ed. West Sussex, UK: Wiley-Blackwell; 2011.
Forno LS. Neuropathology of Parkinson’s disease. J Neuropathol Exp Neurol. 1996;55:259–72.
Hansen LA, Cram BJ. Making the diagnosis of mixed and non-Alzheimer’s dementias. Arch Pathol Lab Med. 1995;119:1023–31.
Hyman BT, Phelps CT, Beach TG, et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement. 2012;8:1–13.
Ironside JW. Prion diseases in man. J Pathol. 1998;186:227–34.
Jellinger KA. Neuropathology of movement disorders. Neurosurg Clin N Am. 1998;9:237–62.
Kovacs GG. Neuropathology of neurodegenerative diseases: a practical guide. Cambridge, UK: Cambridge University Press; 2015.
Li SH, Li XJ. Huntingtin-protein interactions and the pathogenesis of Huntington’s disease. Trends Genet. 2004;20:146–54.
Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ. ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol. 2008;15:772–80.
Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer’s disease. A primer for practicing pathologists. Arch Pathol Lab Med. 1993;117:132–44.
Nance MA. Clinical aspects of CAG repeat diseases. Brain Pathol. 1997;7:881–900.
Stein TD, Alvarez VE, McKee AC. Chronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnel. Alzheimer Res Ther. 2014;6:4.
Trojanowski JQ, Dickson D. Update on the neuropathological diagnosis of frontotemporal dementias. J Neuropathol Exp Neurol. 2001;60:1123–6.
Vinters HV, Ellis WG, Zarow C, et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol. 2000;59:931–45.
Yoshida M. Multiple system atrophy a-synuclein and neuronal degeneration. Neuropathology. 2007;27:484–93.
Inflammatory/Infectious Disorders
Botero D, Tanowitz HB, Weiss LM, Wittner M. Taeniasis and cysticercosis. Infect Dis Clin North Am. 1993;7:683–97.
Burns DK, Risser RC, White CL. The neuropathology of human immunodeficiency virus infection. The Dallas, Texas experience. Arch Pathol Lab Med. 1991;115:1112–24.
Chimelli L, Mahler-Araujo MB. Fungal infections. Brain Pathol. 1997;7:613–27.
Gray F. Bacterial Infections. Brain Pathol. 1997;7:629–47.
Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol. 1993;33:18–27.
Kleinschmidt-DeMasters BK. Central nervous system aspergillosis: a 20-year retrospective series. Hum Pathol. 2002;33:116–24.
Kleinschmidt-DeMasters BK, Gilden DH. The expanding spectrum of herpesvirus infections of the nervous system. Brain Pathol. 2001;11:440–51.
Kuhlmann T, Lassmann H, Brück W. Diagnosis of inflammatory demyelination in biopsy specimens: a practical approach. Acta Neuropathol. 2008;115:275–87.
Nowak DA, Widenka DC. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol. 2001;248:363–72.
Omalu BI, Shakir AA, Wang G, Lipkin WI, Wiley CA. Fatal fulminant pan-meningopolioencephalitis due to West Nile virus. Brain Pathol. 2003;13:465–72.
Thomas G, Murphy S, Staunton H, O’Neill S, Farrell MA, Brett FM. Pathogen-free granulomatous diseases of the central nervous system. Hum Pathol. 1998;29:1110–5.
Zagzag D, Miller DC, Kleinman GM, et al. Demyelinating disease versus tumor in surgical neuropathology. Am J Surg Pathol. 1993;17:537–45.
Pediatric/Developmental
Arid Y, Edwards V, Becker LE. A comparison of cell phenotypes in hemimegalencephaly and tuberous sclerosis. Acta Neuropathol. 1999;98:407–13.
Black M, Graham DI. Sudden unexplained death in adults caused by intracranial pathology. J Clin Pathol. 2002b;55:44–50.
Blümcke I, Thom M, Aronica E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc task force of the ILAE diagnostic methods commission. Epilepsia. 2011;52:158–74.
Blümcke I, Thom M, Aronica E, et al. International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a task force report from the ILAE commission on diagnostic methods. Epilepsia. 2013;54:1315–29.
Frater JL, Prayson RA, Morris III HH, Bingaman WE. Surgical pathologic findings of extratemporal-based intractable epilepsy. A study of 133 consecutive resections. Arch Pathol Lab Med. 2000;124:545–9.
Golden JA. Holoprosencephaly: a defect in brain patterning. J Neuropathol Exp Neurol. 1998;57:991–9.
Luyken C, Blumcke I, Fimmers R, et al. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia. 2003;44:822–30.
Marcorelles P, Laquerriere A. Neuropathology of holoprosencephaly. Am J Med Genet C Semin Med Genet. 2010;154C:109–19.
Mizuguchi M, Takashima S. Neuropathology of tuberous sclerosis. Brain Dev. 2001;23:508–15.
Norman MG. Malformations of the brain. J Neuropathol Exp Neurol. 1996;55:133–43.
Pilz D, Stoodley N, Golden JA. Neuronal migration, cerebral cortical development, and cerebral cortical anomalies. J Neuropathol Exp Neurol. 2002;61:1–11.
Prayson RA. Diagnostic challenges in the evaluation of chronic epilepsy related surgical neuropathology. Am J Surg Pathol. 2010;34:e1–e13.
Volpe JJ. Neurologic outcome of prematurity. Arch Neurol. 1998;55:297–300.
Toxic/Metabolic
Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol. 2009;44:136–40.
Kolodny EH, Cable WJ. Inborn errors of metabolism. Ann Neurol. 1982;11:221–32.
Krill JJ. Neuropathology of thiamine deficiency disorders. Metab Brain Dis. 1996;11:9–17.
Moser HW, Powers JM, Smith KD. Adrenoleukodystrophy: molecular genetics, pathology, and Lorenzo’s oil. Brain Pathol. 1995;5:259–66.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Martin, S.E., Perry, A., Hattab, E.M. (2016). Neuropathology. In: Cheng, L., Bostwick, D. (eds) Essentials of Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-23380-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-23380-2_14
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23379-6
Online ISBN: 978-3-319-23380-2
eBook Packages: MedicineMedicine (R0)